National Institute on Deafness and Other Communication Disorders Draft 2012-2016 Strategic Plan, 66734-66735 [2011-27823]
Download as PDF
66734
Federal Register / Vol. 76, No. 208 / Thursday, October 27, 2011 / Notices
development resources for potential
new therapeutics for the treatment of
cancer. The outcome of the evaluation
will provide information to internal NCI
committees that will decide whether
NCI should support requests and make
available contract resources for
development of the potential
therapeutic to improve the treatment of
various forms of cancer. The research
proposals and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material and personal information
concerning individuals associated with
the proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Experimental Therapeutics Program (NExT).
Date: December 7, 2011.
Time: 8:30 a.m.–4:30 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: Marriott North Conference Center,
5701 Marinelli Road, Rockville, MD 20852.
Contact Person: Dr. Barbara Mroczkowski,
Executive Secretary, NCI Experimental
Therapeutics Program, National Cancer
Institute, NIH, 31 Center Drive, Room 3A44,
Bethesda, MD 20817, (301) 496–4291,
mroczkowskib@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27863 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wreier-aviles on DSK7SPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Mar<15>2010
14:47 Oct 26, 2011
Jkt 226001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Digestive Sciences.
Date: November 14, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Mushtaq A. Khan, D.V.M.,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2176,
MSC 7818, Bethesda, MD 20892, (301) 435–
1778, khanm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Program
Project: Program in Virus Translational
Control.
Date: November 17–18, 2011.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: David R. Jollie, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4150,
MSC 7806, Bethesda, MD 20892, (301) 435–
1722, jollieda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Brain Diseases—Multiple Sclerosis,
Amyotrophic Lateral Sclerosis, Frontal
Temporal Dementia.
Date: November 17, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
Telephone Conference Call).
Contact Person: Samuel C. Edwards, PhD,
IRG Chief, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Program
Project: NMR and Computational Studies of
Biomolecules.
Date: November 21–23, 2011.
Time: 9 a.m. to 11:59 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: James W. Mack, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4154,
MSC 7806, Bethesda, MD 20892, (301) 435–
2037, mackj2@csr.nih.gov.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Viral Pathogenesis and Immunity.
Date: December 1–2, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kenneth M. Izumi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge, Rm 3204, MSC 7808,
Bethesda, MD 20892, (301) 496–6980,
izumikm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893; National
Institutes of Health, HHS)
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27862 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders Draft
2012–2016 Strategic Plan
National Institute on Deafness
and Other Communication Disorders
NIDCD), National Institutes of Health
(NIH), Department of Health and Human
Services (DHHS).
ACTION: Notice.
AGENCY:
The National Institute on
Deafness and Other Communication
Disorders (NIDCD), National Institutes
of Health (NIH) is requesting public
comment on the draft 2012–2016 NIDCD
Strategic Plan. The NIDCD supports and
conducts research and research training
in the areas of hearing and balance;
smell and taste; and voice, speech, and
language. The Strategic Plan serves as a
guide to the NIDCD in prioritizing its
research investment, illustrates the
current state-of-the-science, and
highlights recent advances in the
communication sciences. The draft Plan
presents a series of goals and objectives
that represent the most promising
research needs within the NIDCD’s
mission areas. The draft Plan is
available for download at: https://
www.nidcd.nih.gov/about/plans/
strategic/pages/publiccomments.aspx.
DATES: Comments will be accepted
through November 23, 2011.
SUMMARY:
E:\FR\FM\27OCN1.SGM
27OCN1
Federal Register / Vol. 76, No. 208 / Thursday, October 27, 2011 / Notices
Comments must be
submitted electronically via the Webbased form at: https://
www.nidcd.nih.gov/about/plans/
strategic/pages/publiccomments.aspx.
The Web-based form accepts text but
cannot accept attachments. You will
receive an electronic confirmation
acknowledging receipt of your response,
but will not receive individualized
feedback from NIDCD on any comments.
FOR FURTHER INFORMATION CONTACT:
Specific questions about this Notice
should be directed to:
NIDCDStrategicPlan@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
NIDCD’s mission is to conduct and
support biomedical research, behavioral
research, and research training in the
normal and disordered processes of
hearing, balance, smell, taste, voice,
speech, and language. The institute also
conducts and supports research and
research training related to disease
prevention and health promotion;
addresses special biomedical and
behavioral problems associated with
people who have communication
impairments or disorders; and supports
efforts to create devices that substitute
for lost and impaired sensory and
communication function. To
accomplish these goals, the NIDCD
manages a broad portfolio of both basic
and clinical research. The portfolio is
organized into three program areas:
Hearing and balance; smell and taste;
and voice, speech, and language. The
three program areas seek to answer
fundamental scientific questions about
normal function and disorders and to
identify patient-oriented scientific
discoveries for preventing, screening,
diagnosing, and treating disorders of
human communication.
The draft 2012–2016 NIDCD Strategic
Plan has been developed over the past
12 months by NIDCD staff in
consultation with scientific experts, the
National Deafness and Other
Communication Disorders Advisory
Council, and the public. (Details of the
development process are included in
Appendix C of the draft Plan.) The goals
listed in the draft Plan are an
assessment of research areas that
present the greatest scientific
opportunities and public health needs
over the next five years for the three
program areas: Hearing and balance;
smell and taste; and voice, speech and
language.
The NIDCD has identified four
Priority Areas that have the potential to
increase our understanding of the
normal and disordered processes of
hearing, balance, smell, taste, voice,
speech, and language and to further our
wreier-aviles on DSK7SPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
14:47 Oct 26, 2011
Jkt 226001
knowledge in human communication
sciences. They are:
• Priority Area 1—Understanding
Normal Function: Deepen our
understanding of the mechanisms
underlying normal function of the
systems of human communication. By
defining what is normal in both animal
models and humans, we can better
understand mechanisms of disease.
• Priority Area 2—Understanding
Diseases and Disorders: Increase our
knowledge of the mechanisms of
diseases, disorders, and dysfunctions
that impair human communication and
health. Understanding mechanisms that
underlie diseases and disorders is an
important step in developing better
prevention and treatment strategies.
• Priority Area 3—Improving
Diagnosis, Treatment, and Prevention:
Develop, test, and improve diagnosis,
treatment, and prevention of diseases,
disorders, and dysfunctions of human
communication and health. Diagnosis
considers normal function and provides
targets for prevention and treatment.
Improvements in prevention and
treatment lead to better outcomes with
fewer side effects.
• Priority Area 4—Improving
Outcomes for Human Communication:
Accelerate the translation of research
discoveries into practice; increase
access to health care; and enhance the
delivery, quality, and effectiveness of
care to improve personal and public
health. Scientifically-validated
prevention and treatment models will
lead to better personal and public health
only if they are translated effectively
into routine practice.
The goals presented in the Plan are a
guide for:
• Scientists: To better understand the
directions that NIDCD research may take
in the future;
• The NIDCD: To assist in developing
funding opportunity announcements
and to identify projects for high program
priority nomination; and
• The Public: To understand the state
of communication sciences and to
discover the scientific breakthroughs
that are possible with sustained
investments in biomedical research.
Responses to this Notice are
voluntary. Proprietary, classified,
confidential, or sensitive information
should not be included in your
response. The Government reserves the
right to use any non-proprietary
technical information in any resultant
solicitation(s). Names and affiliation
(when submitted) may be subject to
release in response to requests made
under the U.S. Freedom of Information
Act.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
66735
This Notice is for information and
planning purposes only and should not
be construed as a solicitation or as an
obligation on the part of the Federal
Government, or the NIH. The NIH does
not intend to award a grant or contract
to pay for the preparation of any
information submitted or for the NIH’s
use of such information. No basis for
claims against the NIH shall arise as a
result of a response to this request for
information or the NIH’s use of such
information as part of the NIDCD
Strategic Plan.
The NIDCD anticipates that the
finalized plan will be published on the
NIDCD Web site in January 2012.
Dated: October 20, 2011.
James F. Battey,
Director, NIDCD, National Institutes of
Health.
[FR Doc. 2011–27823 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement of Requirements and
Registration for the NIBIB DEsign by
Biomedical Undergraduate Teams
(DEBUT) Challenge
Authority: 15 U.S.C. 3719.
National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health (NIH),
Department of Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The National Institute of
Biomedical Imaging and Bioengineering
(NIBIB) DEBUT Challenge is open to
teams of undergraduate students
working on projects that develop
innovative solutions to unmet health
and clinical problems. NIBIB’s mission
is to improve health by leading the
development and accelerating the
application of biomedical technologies.
The goals of the DEBUT Challenge are
(1) to provide undergraduate students
valuable experiences such as working in
teams, identifying unmet clinical needs,
and designing, building, and debugging
solutions for such open-ended
problems; (2) to generate novel,
innovative tools to improve health care,
consistent with NIBIB’s purpose to
support research, training,
dissemination of health information,
and other programs with respect to
biomedical imaging and engineering
and associated technologies and
modalities with biomedical
SUMMARY:
E:\FR\FM\27OCN1.SGM
27OCN1
Agencies
[Federal Register Volume 76, Number 208 (Thursday, October 27, 2011)]
[Notices]
[Pages 66734-66735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27823]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders
Draft 2012-2016 Strategic Plan
AGENCY: National Institute on Deafness and Other Communication
Disorders NIDCD), National Institutes of Health (NIH), Department of
Health and Human Services (DHHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute on Deafness and Other Communication
Disorders (NIDCD), National Institutes of Health (NIH) is requesting
public comment on the draft 2012-2016 NIDCD Strategic Plan. The NIDCD
supports and conducts research and research training in the areas of
hearing and balance; smell and taste; and voice, speech, and language.
The Strategic Plan serves as a guide to the NIDCD in prioritizing its
research investment, illustrates the current state-of-the-science, and
highlights recent advances in the communication sciences. The draft
Plan presents a series of goals and objectives that represent the most
promising research needs within the NIDCD's mission areas. The draft
Plan is available for download at: https://www.nidcd.nih.gov/about/plans/strategic/pages/publiccomments.aspx.
DATES: Comments will be accepted through November 23, 2011.
[[Page 66735]]
ADDRESSES: Comments must be submitted electronically via the Web-based
form at: https://www.nidcd.nih.gov/about/plans/strategic/pages/publiccomments.aspx. The Web-based form accepts text but cannot accept
attachments. You will receive an electronic confirmation acknowledging
receipt of your response, but will not receive individualized feedback
from NIDCD on any comments.
FOR FURTHER INFORMATION CONTACT: Specific questions about this Notice
should be directed to: NIDCDStrategicPlan@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The NIDCD's mission is to conduct and
support biomedical research, behavioral research, and research training
in the normal and disordered processes of hearing, balance, smell,
taste, voice, speech, and language. The institute also conducts and
supports research and research training related to disease prevention
and health promotion; addresses special biomedical and behavioral
problems associated with people who have communication impairments or
disorders; and supports efforts to create devices that substitute for
lost and impaired sensory and communication function. To accomplish
these goals, the NIDCD manages a broad portfolio of both basic and
clinical research. The portfolio is organized into three program areas:
Hearing and balance; smell and taste; and voice, speech, and language.
The three program areas seek to answer fundamental scientific questions
about normal function and disorders and to identify patient-oriented
scientific discoveries for preventing, screening, diagnosing, and
treating disorders of human communication.
The draft 2012-2016 NIDCD Strategic Plan has been developed over
the past 12 months by NIDCD staff in consultation with scientific
experts, the National Deafness and Other Communication Disorders
Advisory Council, and the public. (Details of the development process
are included in Appendix C of the draft Plan.) The goals listed in the
draft Plan are an assessment of research areas that present the
greatest scientific opportunities and public health needs over the next
five years for the three program areas: Hearing and balance; smell and
taste; and voice, speech and language.
The NIDCD has identified four Priority Areas that have the
potential to increase our understanding of the normal and disordered
processes of hearing, balance, smell, taste, voice, speech, and
language and to further our knowledge in human communication sciences.
They are:
Priority Area 1--Understanding Normal Function: Deepen our
understanding of the mechanisms underlying normal function of the
systems of human communication. By defining what is normal in both
animal models and humans, we can better understand mechanisms of
disease.
Priority Area 2--Understanding Diseases and Disorders:
Increase our knowledge of the mechanisms of diseases, disorders, and
dysfunctions that impair human communication and health. Understanding
mechanisms that underlie diseases and disorders is an important step in
developing better prevention and treatment strategies.
Priority Area 3--Improving Diagnosis, Treatment, and
Prevention: Develop, test, and improve diagnosis, treatment, and
prevention of diseases, disorders, and dysfunctions of human
communication and health. Diagnosis considers normal function and
provides targets for prevention and treatment. Improvements in
prevention and treatment lead to better outcomes with fewer side
effects.
Priority Area 4--Improving Outcomes for Human
Communication: Accelerate the translation of research discoveries into
practice; increase access to health care; and enhance the delivery,
quality, and effectiveness of care to improve personal and public
health. Scientifically-validated prevention and treatment models will
lead to better personal and public health only if they are translated
effectively into routine practice.
The goals presented in the Plan are a guide for:
Scientists: To better understand the directions that NIDCD
research may take in the future;
The NIDCD: To assist in developing funding opportunity
announcements and to identify projects for high program priority
nomination; and
The Public: To understand the state of communication
sciences and to discover the scientific breakthroughs that are possible
with sustained investments in biomedical research.
Responses to this Notice are voluntary. Proprietary, classified,
confidential, or sensitive information should not be included in your
response. The Government reserves the right to use any non-proprietary
technical information in any resultant solicitation(s). Names and
affiliation (when submitted) may be subject to release in response to
requests made under the U.S. Freedom of Information Act.
This Notice is for information and planning purposes only and
should not be construed as a solicitation or as an obligation on the
part of the Federal Government, or the NIH. The NIH does not intend to
award a grant or contract to pay for the preparation of any information
submitted or for the NIH's use of such information. No basis for claims
against the NIH shall arise as a result of a response to this request
for information or the NIH's use of such information as part of the
NIDCD Strategic Plan.
The NIDCD anticipates that the finalized plan will be published on
the NIDCD Web site in January 2012.
Dated: October 20, 2011.
James F. Battey,
Director, NIDCD, National Institutes of Health.
[FR Doc. 2011-27823 Filed 10-26-11; 8:45 am]
BILLING CODE 4140-01-P